金河生物(002688) - 2019 Q1 - 季度财报

Financial Performance - Revenue for Q1 2019 was CNY 384,630,239.08, representing a 13.95% increase compared to CNY 337,548,703.22 in the same period last year[7] - Net profit attributable to shareholders was CNY 37,734,004.99, up 22.44% from CNY 30,819,150.40 year-over-year[7] - Net profit excluding non-recurring items reached CNY 35,778,746.87, a significant increase of 43.52% compared to CNY 24,930,082.05 in the previous year[7] - Basic earnings per share increased by 20.00% to CNY 0.06 from CNY 0.05 in the same quarter last year[7] - The company reported a total comprehensive income of CNY 34,066,575.69 for Q1 2019, compared to CNY 30,469,344.37 in the same quarter last year[42] - The company's operating profit for Q1 2019 was approximately ¥58.11 million, compared to ¥21.44 million in the same period last year, representing an increase of 171.5%[45] - The net profit for Q1 2019 reached approximately ¥49.33 million, up from ¥18.18 million in Q1 2018, marking a growth of 171.5%[46] - Basic and diluted earnings per share for Q1 2019 were both ¥0.08, compared to ¥0.03 in the same period last year, indicating an increase of 166.7%[46] Assets and Liabilities - Total assets at the end of the reporting period were CNY 3,446,045,189.92, reflecting a 3.32% increase from CNY 3,335,354,103.12 at the end of the previous year[7] - Total current assets increased to ¥1,425,674,790.19 as of March 31, 2019, up from ¥1,315,694,940.70 at the end of 2018, representing a growth of approximately 8.5%[31] - Total liabilities increased to ¥1,631,237,826.77 from ¥1,555,962,970.72, representing a growth of approximately 4.8%[32] - The total liabilities as of Q1 2019 amounted to CNY 968,678,901.22, compared to CNY 854,990,788.11 in the same period last year, reflecting a growth of 13.27%[38] - The company's equity attributable to shareholders increased to ¥1,714,678,437.43 from ¥1,677,942,572.62, reflecting a growth of approximately 2.2%[33] Cash Flow - The net cash flow from operating activities decreased by 65.02% to CNY 3,731,560.95 from CNY 10,666,985.40 in the same period last year[7] - The total cash inflow from operating activities was approximately ¥376.07 million, compared to ¥361.41 million in the previous year, indicating a year-over-year increase of 4.6%[49] - The net cash flow from operating activities was approximately ¥3.73 million, down from ¥10.67 million in the same period last year, reflecting a decrease of 65.0%[49] - The company reported cash inflow from financing activities of approximately ¥380.00 million, an increase from ¥327.43 million in the previous year, representing a growth of 16.0%[50] - The net cash flow from financing activities improved to CNY 118,356,326.55, compared to a negative cash flow of CNY 23,172,630.52 in Q1 2018[54] Expenses and Investments - Research and development expenses increased by 9,748,650.90 yuan, an increase of 102.76%, primarily due to increased investment in R&D across various business segments to enhance market competitiveness[15] - Total operating costs for Q1 2019 were CNY 340,359,134.17, up 11.43% from CNY 305,421,167.03 in Q1 2018[39] - Cash outflow for purchasing goods and services was CNY 122,192,716.84, significantly higher than CNY 60,766,059.88 in Q1 2018, indicating increased operational costs[53] - Cash outflow for employee payments was CNY 36,651,823.74, compared to CNY 30,871,566.23 in the previous year, reflecting a 18.7% increase[53] - The company reported a cash outflow from investing activities of approximately ¥29.81 million, compared to ¥36.63 million in the previous year, indicating a decrease of 18.8%[50] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 30,666[10] - The largest shareholder, Inner Mongolia Jinhai Construction Installation Co., Ltd., held 38.05% of the shares, amounting to 241,758,670 shares[10] - The company’s non-public issuance of 90,689,655 shares, accounting for 14.2753% of the total share capital, was released for trading on February 11, 2019[20]